Risk factors: Schizophrenia
Kegg pathways Schizophrenia gene pathways, including Toxoplasmosis
Artemisinin reduces the level of antibodies to gliadin in schizophrenia
Artemisinin is an antimalarial that also has activity against T.Gondii: It reduces the level of antibodies to gliadin, but not to T.Gondii in schizophrenia, but was without effect on symptoms in neuroleptic treated patients.
Risk factors: Schizophrenia
Kegg pathways Schizophrenia gene pathways, including Toxoplasmosis
Risk factors: Schizophrenia
Kegg pathways Schizophrenia gene pathways, including Toxoplasmosis
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment